HEMAGEN DIAGNOSTICS INCORPORATED's ticker is HMGN and the CUSIP is 423501105. A total of 1 filers reported holding HEMAGEN DIAGNOSTICS INCORPORATED in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | – | 51,500 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 51,500 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 51,500 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 51,500 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 51,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Formidable Asset Management, LLC | 51,500 | $0 | 0.00% |